EU Seeking Firms To Offer ‘Ever-Warm’ Production Capacity For Future Pandemics
Executive Summary
The EU is drawing on lessons learned during the COVID-19 pandemic to set up a network of vaccine production capacities able to respond quickly to a surge in demand.
You may also be interested in...
EU Wants Pharma To Offer ‘Ever-Warm’ Vaccine & Drug Production Capacity
As part of its efforts to bolster Europe’s readiness for health emergencies, the European Commission wants to make sure that additional production capacity is available at short notice.
EU Bodies Agree Clearer Rules On Joint Procurement Of Vaccines & Treatments
The new regulation on cross-border threats to health is the final part of the European Health Union, along with strengthened roles for the European Medicines Agency and the European Centre for Disease Prevention and Control. Its aim is to ensure collective EU action on preparedness, surveillance, risk assessment, and early warning and response in the event of health emergencies.
International Regulators Plan Roadmap For Collaborative RWE Studies
Experiences during the COVID-19 pandemic are expected to help identify future opportunities for regulatory cooperation on real-world evidence and avoid divergent decision-making for products including advanced therapies and personalized medicines.